Ascendis Pharma A/S - ADR

NASDAQ:ASND  
163.74
-4.56 (-2.71%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)9.06B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.75 Million
Adjusted EPS-$2.70
See more estimates
10-Day MA$160.46
50-Day MA$136.95
200-Day MA$142.86
See more pivots

Ascendis Pharma A/S - ADR Stock, NASDAQ:ASND

Tuborg Boulevard 12, Hellerup, Capital Region 2900
Denmark
Phone: +45.70.22.22.44
Number of Employees:

Description

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.